The present invention provides novel anticode oligomers and methods of using them for controlling the growth of cancer cells expressing the bcl-2 gene.

 
Web www.patentalert.com

< Hepatitis C virus codon optimized non-structural NS3/4A fusion gene

< T cell binding ligand peptides and method of inducing a cellular immune response

> Oligonucleotides containing an antisense sequence stabilized by a secondary structure, pharmaceutical compositions containing them and method of blocking gene expression using them

> Isotopically labelled DNA
~ 00249